Work

Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis

Year: 2017
Type: article
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,590
OpenAlex ID: W2588055063
FWCI: 2.304
Cites: 9
Cited by: 12
Related to: 10